Federal Trade Commission

FTC Files Amicus Brief Highlighting Anticompetitive Harm from Improperly Listed Patents in FDA’s ‘Orange Book’

The Federal Trade Commission (FTC) filed an amicus brief on November 20, 2023, addressing the anticompetitive harm resulting from improperly listed patents in the Food and Drug Administration’s (FDA) “Approved …

FTC Files Amicus Brief Highlighting Anticompetitive Harm from Improperly Listed Patents in FDA’s ‘Orange Book’ Read More
United States Capitol from House of Representatives

U.S. Senators Pass Outbound Investment Transparency Act to Screen National Security Investments in Countries of Concern

U.S. Senators Bob Casey (D-PA) and John Cornyn (R-TX) announced on Tuesday the passage of their bill, the Outbound Investment Transparency Act, which aims to screen U.S. investments in national …

U.S. Senators Pass Outbound Investment Transparency Act to Screen National Security Investments in Countries of Concern Read More